AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Positive results reported for anastrozole in breast cancer treatment study.(Arimidex)(Brief Article)
2003 JAN 16 - (NewsRx.com & NewsRx.net) -- Updated results from the ongoing Arimidex (anastrozole) early breast cancer trial were presented in San Antonio, Texas, indicating that Arimidex continues to show a statistically significant improvement in recurrence-free survival over tamoxifen.
The updated results were based on an analysis of data at a median treatment duration of nearly 4 years (47 months).
Importantly, more than 1400 patients in the Arimidex and tamoxifen arms of the study have now been followed for more than 54 months, nearing the 5-year standard treatment period generally used in the adjuvant setting. Arimidex is the only drug to show improvement over tamoxifen in early breast cancer.
The U.S. Food and Drug Administration (FDA) approval of Arimidex for the adjuvant treatment of hormone-receptor-positive early breast cancer in postmenopausal women was based on analysis of data from this trial at a median duration of treatment of 31 months, with further follow-up required to determine ...
- ARIMIDEX(R) (anastrozole) Gains Full FDA Approval for Adjuvant Treatment of...
- Press release article from: PR Newswire September 19, 2005 700+ words
...years of follow-up on ARIMIDEX use in early breast cancer. The ATAC trial is...after surgery for early breast cancer. ARIMIDEX and tamoxifen remain...postmenopausal women with early breast cancer. About ARIMIDEX(R) ARIMIDEX is indicated...
- Trials Underway to Evaluate ARIMIDEX in Postmenopausal Women at High-Risk For...
- Press release article from: PR Newswire May 28, 2003 700+ words
...receptor- positive early breast cancer. ARIMIDEX is the only hormonal drug...survival from the ongoing ARIMIDEX early breast cancer trial (ATAC) in patients...yet developed invasive breast cancer." ARIMIDEX is a prescription medication...
- FDA Approves Arimidex, a New First Line Treatment Option for Breast Cancer.
- Press release article from: PR Newswire September 5, 2000 700+ words
...approved its breast cancer treatment Arimidex(R) (anastrozole...locally advanced breast cancer whose cancers...receptive. ARIMIDEX is the first...receptor positive breast cancer received the...benefit from ARIMIDEX. At least 10...
- FDA Approves ARIMIDEX, a New First Line Treatment Option for Breast Cancer.
- Press release article from: Business Wire September 1, 2000 700+ words
...approved its breast cancer treatment Arimidex(R) (anastrozole...locally advanced breast cancer whose cancers...receptive. ARIMIDEX is the first...receptor positive breast cancer received the...benefit from ARIMIDEX. At least 10...
- ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of Switching on...
- Press release article from: PR Newswire December 9, 2005 700+ words
...largest studies of breast cancer treatment after surgery, the Arimidex, Tamoxifen...positive early breast cancer. Important...Information About ARIMIDEX ARIMIDEX should...effects seen with ARIMIDEX in the early breast cancer clinical trial...
- New 5-Year Data Reported Comparing ARIMIDEX(R) (anastrozole) to Tamoxifen in...
- Press release article from: PR Newswire December 8, 2004 700+ words
...FDA as long-term follow-up on ARIMIDEX use in early breast cancer. Updated results at a median follow...hormone receptor-positive early breast cancer. The effectiveness of ARIMIDEX in early breast cancer is based on an analysis of recurrence...
- Data Presented Today Show ARIMIDEX(R) Combined With Herceptin(R) Extended...
- Press release article from: PR Newswire December 14, 2006 700+ words
...the San Antonio Breast Cancer Symposium SAN ANTONIO...women who received ARIMIDEX (anastrozole...2006 San Antonio Breast Cancer Symposium (SABCS...participants who received ARIMIDEX and Herceptin in...child. In advanced breast cancer clinical trials...effects seen with ...
- ASCO Working Group Assesses Updated Trial Results on ARIMIDEX (R) (Anastrozole)...
- Press release article from: PR Newswire May 12, 2003 700+ words
...follow-up data from the ARIMIDEX early breast cancer trial (ATAC -- ARIMIDEX...survival from the ongoing ARIMIDEX early breast cancer trial (ATAC) in patients...option with their early breast cancer patients." "ARIMIDEX gave me an alternative...
Source: HighBeam Research, Positive results reported for anastrozole in breast cancer treatment...